ArticleJournal of biological engineering2026
Years-long stability of X10 expansion microscopy hydrogels.
Article in Journal of biological engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Expansion microscopy (ExM) is developing rapidly to explore biological structures, both towards nanoscale imaging and the wider-scale analysis of cells and tissues. ExM is based on embedding samples in swellable hydrogels, which then expand to enable superior microscopy performance with conventional microscopes. However, imaging precision is limited by the stability of the hydrogels, which are typically regarded as less robust than conventional samples. Here, we show that hydrogels based on N, N-dimethylacrylamide (DMAA) remain stable for several years, without a perceivable loss of structure. No special measures of stabilization are necessary for the gel matrix, but post-fixation is required to maintain the integrity of antibody labeling, when post-expansion labeling procedures are employed. Otherwise, antibodies slowly lose epitope binding over years, corrupting both signal intensity and resolution. We conclude that ExM hydrogels are substantially more robust than previously envisioned, enhancing signal intensity and enabling years-long performance, with minimal care. Moreover, this paves the avenue to re-imaging, inter-lab sample exchange, and retrospective analyses, which could be employed in medical applications ranging from diagnostic validation and biomarker discovery to comparative studies across time points or cohorts. This approach extends ExM from a single-use technique to a platform compatible with sustained experimental workflows.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.